Press Releases Ypsomed Group

Burgdorf - Ypsomed is pleased to announce that it has granted to Cilag GmbH International, a non exclusive licence to use certain patents, which protect inventions of Ypsomed, for an autoinjector device for the administration of two biopharmaceutical products with an option to extend the licence for a number of other compounds. Ypsomed is not in a position to communicate the commercial details of the agreement, but expects to receive significant royalties over the term of the contract.

Go Back